Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Jan 2024
Impressive efficacy and a favorable safety profile are demonstrated by the study results in the second line.
Read Full NewsA new study will follow adults with chronic inflammatory demyelinating polyradiculoneuropathy who start subcutaneous efgartigimod in routine practice in the US and Germany.
The FDA accepted fenebrutinib's new drug application under priority review for relapsing and primary progressive MS, based on 3 phase 3 trials comparing the BTK inhibitor with teriflunomide and ocrelizumab.
Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Katherine Matthews, MD. [LISTEN TIME: 17 minutes]
Findings from the phase 1/2 RESET-MG trial, presented at AANEM 2026, showed that 10 of 13 patients with refractory generalized myasthenia gravis had clinically meaningful MG-ADL improvements after a single infusion of rese-cel.
In a pivotal phase 3 study, once-daily tasimelteon 20 mg shifted sleep onset 37.1 minutes earlier than placebo in adults with delayed sleep-wake phase disorder.
PETUNIA, a new global pharmacovigilance study, will track pregnancy, maternal, and infant outcomes among patients with gMG exposed to nipocalimab.
In this segment from the latest episode of Diabetes Dialogue, Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the commercial release of insulin icodec.
1.
A Possible Novel CAR-T Treatment for High-Risk R/R Follicular Lymphoma May Be Liso-Cel.
2.
FAPI PET/CT enhances the staging of recently discovered breast cancer, according to comparative analysis.
3.
ASCO Future Focus: Follicular Lymphoma: Future Focus from the American Society of Clinical Onology
4.
a cutting-edge cancer diagnostic tool.
5.
The FDA Approves the New Frontline Aggressive ALL Regimen.
1.
Remote Hematology Follow-Up: Advancements, Clinical Implications, and Future Directions
2.
Transformative Approaches in Hematology for Healthcare Excellence
3.
Case-Based Learning: Reasoning Through New Functional Changes During Long-Term Cancer Survivorship
4.
Exercise Capacity During Cancer Recovery: Clinical Evidence, Mechanisms, and Practical Implications
5.
Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
2.
Understanding Common Causes of Abnormal Blood Counts
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
4.
Understanding the Role of Multidisciplinary Cancer Care
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge